A Phase II, Dose Ranging, Exploratory Clinical Study to Assess the Efficacy, Pharmacodynamics, and Safety of LNP1955 in Patients with Moderate-to-Severe Plaque Psoriasis II.
Latest Information Update: 30 Oct 2017
At a glance
- Drugs LNP 1955 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Lupin
- 27 Oct 2017 Status changed from recruiting to completed.
- 13 Sep 2016 New trial record